114 related articles for article (PubMed ID: 3673167)
1. [Treatment of hypertrophic cardiomyopathy with nifedipine and propranolol in combination].
Hopf R; Thomas J; Klepzig H; Kaltenbach M
Z Kardiol; 1987 Aug; 76(8):469-78. PubMed ID: 3673167
[TBL] [Abstract][Full Text] [Related]
2. Effects of nifedipine and propranolol combined therapy in patients with hypertrophic cardiomyopathy.
Hopf R; Kaltenbach M
Z Kardiol; 1987; 76 Suppl 3():105-12. PubMed ID: 3433863
[TBL] [Abstract][Full Text] [Related]
3. [Long-term therapy of hypertrophic obstructive and non-obstructive cardiomyopathy with nifedipine in comparison to propranolol].
Cserhalmi L; Assmann I; Glavanov M; Rev J; Kelecseńeyi Z
Z Gesamte Inn Med; 1984 Jul; 39(14):330-5. PubMed ID: 6435321
[TBL] [Abstract][Full Text] [Related]
4. [Comparative study of the effects of verapamil and propranolol therapy in 16 cases of obstructive hypertrophic myocardiopathy].
Cosnay P; Fauchier JP; Lang M; Casset D; Raynaud P; Lavigne G; Itti R
Arch Mal Coeur Vaiss; 1987 Mar; 80(3):346-55. PubMed ID: 3113357
[TBL] [Abstract][Full Text] [Related]
5. [Echocardiographic and electrocardiographic evaluation of the effects of propranolol and verapamil in obstructive hypertrophic cardiomyopathy].
Crittin J; Mayor C; Bloch A
Ann Cardiol Angeiol (Paris); 1984 Apr; 33(3):185-9. PubMed ID: 6375537
[TBL] [Abstract][Full Text] [Related]
6. Long-term treatment of hypertrophic cardiomyopathy with verapamil or propranolol in matched pairs of patients: results of a multicenter study.
Kober G; Hopf R; Biamino G; Bubenheimer P; Förster K; Kuck KH; Hanrath P; von Olshausen KE; Schlepper M; Kaltenbach M
Z Kardiol; 1987; 76 Suppl 3():113-8. PubMed ID: 3324526
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic long-term results after medical and surgical therapy of hypertrophic cardiomyopathies.
Lösse B; Loogen F; Schulte HD
Z Kardiol; 1987; 76 Suppl 3():119-30. PubMed ID: 3433864
[TBL] [Abstract][Full Text] [Related]
8. [Hypertrophic obstructive cardiomyopathy: spontaneous course in comparison to long-term therapy with propranolol and verapamil].
Haberer T; Hess OM; Jenni R; Krayenbühl HP
Z Kardiol; 1983 Sep; 72(9):487-93. PubMed ID: 6415946
[TBL] [Abstract][Full Text] [Related]
9. Effects of nicardipine or nifedipine added to propranolol in patients with coronary artery disease.
Pouleur H; Etienne J; Van Mechelen H; Van Eyll C; Charlier AA; Brasseur LA; Rousseau MF
Postgrad Med J; 1984; 60 Suppl 4():23-8. PubMed ID: 6527976
[TBL] [Abstract][Full Text] [Related]
10. [Conservative medical treatment of hypertrophic myocardiopathies].
Kaltenbach M; Hopf R
Z Kardiol; 1982 Dec; 71(12):795-805. PubMed ID: 6891871
[TBL] [Abstract][Full Text] [Related]
11. [Hemodynamic effects of medical and surgical therapy of hypertrophic obstructive cardiomyopathy (author's transl)].
Lösse B; Kuhn H; Krönert H; Rafflenbeul D; Kirschner P; Schulte HD; Loogen F
Z Kardiol; 1980 Jul; 69(7):470-7. PubMed ID: 7192456
[TBL] [Abstract][Full Text] [Related]
12. Combination of disopyramide and propranolol in hypertrophic cardiomyopathy.
Cokkinos DV; Salpeas D; Ioannou NE; Christoulas S
Can J Cardiol; 1989; 5(1):33-6. PubMed ID: 2920304
[TBL] [Abstract][Full Text] [Related]
13. [Nifedipine in the treatment of hypertrophic non-obstructive cardiomyopathy].
Senn M; Hess OM; Krayenbühl HP
Schweiz Med Wochenschr; 1982 Sep; 112(38):1312-7. PubMed ID: 6215710
[TBL] [Abstract][Full Text] [Related]
14. Haemodynamic effects of nifedipine and propranolol in patients with hypertrophic obstructive cardiomyopathy.
Landmark K; Sire S; Thaulow E; Amlie JP; Nitter-Hauge S
Br Heart J; 1982 Jul; 48(1):19-26. PubMed ID: 7200796
[TBL] [Abstract][Full Text] [Related]
15. [Drug treatment of hypertrophic cardiomyopathy].
Hirzel HO
Herz; 1985 Apr; 10(2):84-90. PubMed ID: 4039293
[TBL] [Abstract][Full Text] [Related]
16. [Beta-adrenergic blockers and calcium antagonists in hypertrophic cardiomyopathy].
Korovina EP
Klin Med (Mosk); 1998; 76(12):30-5. PubMed ID: 10067289
[TBL] [Abstract][Full Text] [Related]
17. [Outcome of hypertrophic and obstructive myocardiopathies treated with high doses of propranolol].
Bourmayan C; Dussaule JC; Artigou JY; Fournier C; Fernandez F; Desnos M; Gerbaux A; Gay J
Arch Mal Coeur Vaiss; 1985 Sep; 78(9):1409-16. PubMed ID: 3936444
[TBL] [Abstract][Full Text] [Related]
18. Myocardial biopsy in patients with hypertrophic cardiomyopathy: correlations between morphologic and clinical parameters and development of myocardial hypertrophy under medical therapy.
Kunkel B; Schneider M; Eisenmenger A; Bergmann B; Hopf R; Kaltenbach M
Z Kardiol; 1987; 76 Suppl 3():33-8. PubMed ID: 2963449
[TBL] [Abstract][Full Text] [Related]
19. [Medical treatment of hypertrophic myocardiopathy. Comparison of propranolol and verapamil].
Bouhour JB; Potiron M; Chiffoleau S; Lefévre M; Louvet S
Arch Mal Coeur Vaiss; 1987 Jan; 80(1):76-82. PubMed ID: 3107495
[TBL] [Abstract][Full Text] [Related]
20. [Results of long-term verapamil treatment of patients with hypertrophic cardiomyopathy].
Dabrowski M; Michalak E; Maurin A; Rydlewska-Sadowska W; Ruzyłło W
Kardiol Pol; 1989; 32 Suppl 2():6-16. PubMed ID: 2634154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
